The present invention relates to biobased polyglyceryl ester compounds and compositions and formulations comprising same, processes for preparing the inventive biobased polyglyceryl ester compositions, as well as applications thereof including the use of the inventive compounds and compositions in formulations of products or components of products. The biobased polyglyceryl ester composition may comprise a mixture including one or more compounds of Formula (I):

##STR00001## wherein: PG is a polyglyceryl group comprising greater than 40% hexaglycerol and higher polyglycerols and less than 60% pentaglycerol and lower polyglycerols, R is a linear or branched C.sub.5-C.sub.8 alkyl group, n=from 1 to 3, and wherein substantially all of the carbon present in the one or more compounds of Formula (I) is biobased.

The present invention relates to biobased polyglyceryl ester compounds and compositions and formulations comprising same, processes for preparing the inventive biobased polyglyceryl ester compositions, as well as applications thereof including the use of the inventive compounds and compositions in formulations of products or components of products. The biobased polyglyceryl ester composition may comprise a mixture including one or more compounds of Formula (I):

##STR00001## wherein: PG is a polyglyceryl group comprising greater than 40% hexaglycerol and higher polyglycerols and less than 60% pentaglycerol and lower polyglycerols, R is a linear or branched C.sub.5-C.sub.8 alkyl group, n=from 1 to 3, and wherein substantially all of the carbon present in the one or more compounds of Formula (I) is biobased.

There is provided a method of preparing a hybrid capsule, the method comprising heterocoagulating organic polymer latex particles with a primary capsule to form an organic polymer coating layer over a shell of the primary capsule.

The subject application relates to topical preparations comprising polyalkoxylated polyols polyester with Guerbet acid. Compounds contained herein relate to polyalkoxylated polyol polyesters having a viscosity that allows a product to be poured, yet retained on a desired surface to which it is applied. Embodiments of the compounds may be exemplified by the formula:

Q-[(OA).sub.n-OR].sub.m

The subject application relates to topical preparations comprising polyalkoxylated polyols polyester with Guerbet acid. Compounds contained herein relate to polyalkoxylated polyol polyesters having a viscosity that allows a product to be poured, yet retained on a desired surface to which it is applied. Embodiments of the compounds may be exemplified by the formula:

Q-[(OA).sub.n-OR].sub.m

Method for manufacturing microcapsules enclosing a substance referred to as the active substance, in which method: there are provided an aqueous solution of a surfactant, an oily phase comprising the active substance and at least a first monomer X, and a polar phase having at least a second monomer Y; an O/W emulsion is prepared by adding the oily phase to the aqueous solution of the surfactant; the polar phase is added to the O/W emulsion in order to obtain a polymer by polymerisation of the X and Y monomers; starting from this reaction mixture, the microcapsules are isolated and comprise a wall which is formed by the polymer and which encloses the active substance; the polymer is a poly(beta-amino ester).

The present disclosure relates to a biodegradable polymer dispersion containing a lactic acid-based polymer, a lactic acid-based polymer and polyethylene glycol-containing block copolymer (PEG-PLA), and a hyaluronic acid mixture, wherein the biodegradable polymer dispersion has excellent physiological activity by itself, has excellent dispersion stability of the lactic acid-based polymer, and is capable of effectively supporting active ingredients. In addition, the present disclosure relates to a composition containing the biodegradable polymer dispersion and a skin improvement system.

The present invention provides a method of suppressing hunger by lowering plasma ghrelin levels comprising administration of a compound to a human or animal body, wherein the compound is selected from: (i) (R)-3-hydroxybutyrate; (ii) an ester of (R)-3-hydroxybutyrate; and (iii) an oligomer of (R)-3-hydroxybutyrate moieties; or a pharmaceutically acceptable salt or solvate thereof. The invention also provides a method of administering such a compound in a dosage effective to reduce hunger in order that a cosmetically beneficial loss or maintenance of body weight occurs, wherein in the method, plasma ghrelin levels are lowered. The aforementioned compound is also provided for use in a method of treatment of the human or animal body wherein the compound is administered and hunger is suppressed by lowering of plasma ghrelin levels. The compound is particularly useful for subjects having conditions associated with overeating, such as overweight, obese, severely obese patients or diabetic patients.

Provided are coated particles and methods of their use for providing healthcare benefits. More specifically, the present invention provides amino acid and/or polymer-coated particles, or particles coated with other materials, for binding to, or otherwise associating with, surfaces of the oral cavity.

Provided are coated particles and methods of their use for providing healthcare benefits. More specifically, the present invention provides amino acid and/or polymer-coated particles, or particles coated with other materials, for binding to, or otherwise associating with, surfaces of the oral cavity.